Global Infectious Diseases In Vitro Diagnostics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 186023
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Infectious Diseases In Vitro Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Infectious Diseases In Vitro Diagnostics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Infectious Diseases In Vitro Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Infectious Diseases In Vitro Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

MRSA

Streptococcus

TB and Drug-resistant TB

Gastro-intestinal Panel Testing

HIV

Hepatitis C

Others

Market segment by Application, can be divided into

Immunochemistry

Molecular Diagnostics

Microbiology

Others

Market segment by players, this report covers

BD

Abbott

Alere

Quidel

F. Hoffmann-La Roche

Orasure Technologies

Cepheid

Hologic

Qiagen

Bio-Rad Laboratories

Siemens Healthcare

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Infectious Diseases In Vitro Diagnostics

1.2 Classification of Infectious Diseases In Vitro Diagnostics by Type

1.2.1 Overview: Global Infectious Diseases In Vitro Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type in 2020

1.2.3 MRSA

1.2.4 Streptococcus

1.2.5 TB and Drug-resistant TB

1.2.6 Gastro-intestinal Panel Testing

1.2.7 HIV

1.2.8 Hepatitis C

1.2.9 Others

1.3 Global Infectious Diseases In Vitro Diagnostics Market by Application

1.3.1 Overview: Global Infectious Diseases In Vitro Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Immunochemistry

1.3.3 Molecular Diagnostics

1.3.4 Microbiology

1.3.5 Others

1.4 Global Infectious Diseases In Vitro Diagnostics Market Size & Forecast

1.5 Global Infectious Diseases In Vitro Diagnostics Market Size and Forecast by Region

1.5.1 Global Infectious Diseases In Vitro Diagnostics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Infectious Diseases In Vitro Diagnostics Market Size by Region, (2016-2021)

1.5.3 North America Infectious Diseases In Vitro Diagnostics Market Size and Prospect (2016-2026)

1.5.4 Europe Infectious Diseases In Vitro Diagnostics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size and Prospect (2016-2026)

1.5.6 South America Infectious Diseases In Vitro Diagnostics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Infectious Diseases In Vitro Diagnostics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Infectious Diseases In Vitro Diagnostics Market Drivers

1.6.2 Infectious Diseases In Vitro Diagnostics Market Restraints

1.6.3 Infectious Diseases In Vitro Diagnostics Trends Analysis

2 Company Profiles

2.1 BD

2.1.1 BD Details

2.1.2 BD Major Business

2.1.3 BD Infectious Diseases In Vitro Diagnostics Product and Solutions

2.1.4 BD Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 BD Recent Developments and Future Plans

2.2 Abbott

2.2.1 Abbott Details

2.2.2 Abbott Major Business

2.2.3 Abbott Infectious Diseases In Vitro Diagnostics Product and Solutions

2.2.4 Abbott Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Abbott Recent Developments and Future Plans

2.3 Alere

2.3.1 Alere Details

2.3.2 Alere Major Business

2.3.3 Alere Infectious Diseases In Vitro Diagnostics Product and Solutions

2.3.4 Alere Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Alere Recent Developments and Future Plans

2.4 Quidel

2.4.1 Quidel Details

2.4.2 Quidel Major Business

2.4.3 Quidel Infectious Diseases In Vitro Diagnostics Product and Solutions

2.4.4 Quidel Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Quidel Recent Developments and Future Plans

2.5 F. Hoffmann-La Roche

2.5.1 F. Hoffmann-La Roche Details

2.5.2 F. Hoffmann-La Roche Major Business

2.5.3 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product and Solutions

2.5.4 F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 F. Hoffmann-La Roche Recent Developments and Future Plans

2.6 Orasure Technologies

2.6.1 Orasure Technologies Details

2.6.2 Orasure Technologies Major Business

2.6.3 Orasure Technologies Infectious Diseases In Vitro Diagnostics Product and Solutions

2.6.4 Orasure Technologies Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Orasure Technologies Recent Developments and Future Plans

2.7 Cepheid

2.7.1 Cepheid Details

2.7.2 Cepheid Major Business

2.7.3 Cepheid Infectious Diseases In Vitro Diagnostics Product and Solutions

2.7.4 Cepheid Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Cepheid Recent Developments and Future Plans

2.8 Hologic

2.8.1 Hologic Details

2.8.2 Hologic Major Business

2.8.3 Hologic Infectious Diseases In Vitro Diagnostics Product and Solutions

2.8.4 Hologic Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Hologic Recent Developments and Future Plans

2.9 Qiagen

2.9.1 Qiagen Details

2.9.2 Qiagen Major Business

2.9.3 Qiagen Infectious Diseases In Vitro Diagnostics Product and Solutions

2.9.4 Qiagen Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Qiagen Recent Developments and Future Plans

2.10 Bio-Rad Laboratories

2.10.1 Bio-Rad Laboratories Details

2.10.2 Bio-Rad Laboratories Major Business

2.10.3 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product and Solutions

2.10.4 Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Bio-Rad Laboratories Recent Developments and Future Plans

2.11 Siemens Healthcare

2.11.1 Siemens Healthcare Details

2.11.2 Siemens Healthcare Major Business

2.11.3 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product and Solutions

2.11.4 Siemens Healthcare Infectious Diseases In Vitro Diagnostics Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Siemens Healthcare Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Infectious Diseases In Vitro Diagnostics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Infectious Diseases In Vitro Diagnostics Players Market Share

3.2.2 Top 10 Infectious Diseases In Vitro Diagnostics Players Market Share

3.2.3 Market Competition Trend

3.3 Infectious Diseases In Vitro Diagnostics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Infectious Diseases In Vitro Diagnostics Revenue and Market Share by Type (2016-2021)

4.2 Global Infectious Diseases In Vitro Diagnostics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Application (2016-2021)

5.2 Infectious Diseases In Vitro Diagnostics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Infectious Diseases In Vitro Diagnostics Revenue by Type (2016-2026)

6.2 North America Infectious Diseases In Vitro Diagnostics Revenue by Application (2016-2026)

6.3 North America Infectious Diseases In Vitro Diagnostics Market Size by Country

6.3.1 North America Infectious Diseases In Vitro Diagnostics Revenue by Country (2016-2026)

6.3.2 United States Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

6.3.3 Canada Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

6.3.4 Mexico Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Infectious Diseases In Vitro Diagnostics Revenue by Type (2016-2026)

7.2 Europe Infectious Diseases In Vitro Diagnostics Revenue by Application (2016-2026)

7.3 Europe Infectious Diseases In Vitro Diagnostics Market Size by Country

7.3.1 Europe Infectious Diseases In Vitro Diagnostics Revenue by Country (2016-2026)

7.3.2 Germany Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

7.3.3 France Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

7.3.5 Russia Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

7.3.6 Italy Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Infectious Diseases In Vitro Diagnostics Revenue by Type (2016-2026)

8.2 Asia-Pacific Infectious Diseases In Vitro Diagnostics Revenue by Application (2016-2026)

8.3 Asia-Pacific Infectious Diseases In Vitro Diagnostics Market Size by Region

8.3.1 Asia-Pacific Infectious Diseases In Vitro Diagnostics Revenue by Region (2016-2026)

8.3.2 China Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

8.3.3 Japan Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

8.3.4 South Korea Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

8.3.5 India Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

8.3.7 Australia Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Infectious Diseases In Vitro Diagnostics Revenue by Type (2016-2026)

9.2 South America Infectious Diseases In Vitro Diagnostics Revenue by Application (2016-2026)

9.3 South America Infectious Diseases In Vitro Diagnostics Market Size by Country

9.3.1 South America Infectious Diseases In Vitro Diagnostics Revenue by Country (2016-2026)

9.3.2 Brazil Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

9.3.3 Argentina Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Infectious Diseases In Vitro Diagnostics Revenue by Type (2016-2026)

10.2 Middle East & Africa Infectious Diseases In Vitro Diagnostics Revenue by Application (2016-2026)

10.3 Middle East & Africa Infectious Diseases In Vitro Diagnostics Market Size by Country

10.3.1 Middle East & Africa Infectious Diseases In Vitro Diagnostics Revenue by Country (2016-2026)

10.3.2 Turkey Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

10.3.4 UAE Infectious Diseases In Vitro Diagnostics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Infectious Diseases In Vitro Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Infectious Diseases In Vitro Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Infectious Diseases In Vitro Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Infectious Diseases In Vitro Diagnostics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Region (2021-2026)

Table 6. BD Corporate Information, Head Office, and Major Competitors

Table 7. BD Major Business

Table 8. BD Infectious Diseases In Vitro Diagnostics Product and Solutions

Table 9. BD Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Abbott Corporate Information, Head Office, and Major Competitors

Table 11. Abbott Major Business

Table 12. Abbott Infectious Diseases In Vitro Diagnostics Product and Solutions

Table 13. Abbott Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Alere Corporate Information, Head Office, and Major Competitors

Table 15. Alere Major Business

Table 16. Alere Infectious Diseases In Vitro Diagnostics Product and Solutions

Table 17. Alere Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Quidel Corporate Information, Head Office, and Major Competitors

Table 19. Quidel Major Business

Table 20. Quidel Infectious Diseases In Vitro Diagnostics Product and Solutions

Table 21. Quidel Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors

Table 23. F. Hoffmann-La Roche Major Business

Table 24. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Product and Solutions

Table 25. F. Hoffmann-La Roche Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Orasure Technologies Corporate Information, Head Office, and Major Competitors

Table 27. Orasure Technologies Major Business

Table 28. Orasure Technologies Infectious Diseases In Vitro Diagnostics Product and Solutions

Table 29. Orasure Technologies Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Cepheid Corporate Information, Head Office, and Major Competitors

Table 31. Cepheid Major Business

Table 32. Cepheid Infectious Diseases In Vitro Diagnostics Product and Solutions

Table 33. Cepheid Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Hologic Corporate Information, Head Office, and Major Competitors

Table 35. Hologic Major Business

Table 36. Hologic Infectious Diseases In Vitro Diagnostics Product and Solutions

Table 37. Hologic Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Qiagen Corporate Information, Head Office, and Major Competitors

Table 39. Qiagen Major Business

Table 40. Qiagen Infectious Diseases In Vitro Diagnostics Product and Solutions

Table 41. Qiagen Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 43. Bio-Rad Laboratories Major Business

Table 44. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Product and Solutions

Table 45. Bio-Rad Laboratories Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Siemens Healthcare Corporate Information, Head Office, and Major Competitors

Table 47. Siemens Healthcare Major Business

Table 48. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Product and Solutions

Table 49. Siemens Healthcare Infectious Diseases In Vitro Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Global Infectious Diseases In Vitro Diagnostics Revenue (USD Million) by Players (2019-2021)

Table 51. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Players (2019-2021)

Table 52. Breakdown of Infectious Diseases In Vitro Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 53. Infectious Diseases In Vitro Diagnostics Players Head Office, Products and Services Provided

Table 54. Infectious Diseases In Vitro Diagnostics Mergers & Acquisitions in the Past Five Years

Table 55. Infectious Diseases In Vitro Diagnostics New Entrants and Expansion Plans

Table 56. Global Infectious Diseases In Vitro Diagnostics Revenue (USD Million) by Type (2016-2021)

Table 57. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Type (2016-2021)

Table 58. Global Infectious Diseases In Vitro Diagnostics Revenue Forecast by Type (2021-2026)

Table 59. Global Infectious Diseases In Vitro Diagnostics Revenue by Application (2016-2021)

Table 60. Global Infectious Diseases In Vitro Diagnostics Revenue Forecast by Application (2021-2026)

Table 61. North America Infectious Diseases In Vitro Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 62. North America Infectious Diseases In Vitro Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 63. North America Infectious Diseases In Vitro Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 64. North America Infectious Diseases In Vitro Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 65. North America Infectious Diseases In Vitro Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 66. North America Infectious Diseases In Vitro Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 67. Europe Infectious Diseases In Vitro Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 68. Europe Infectious Diseases In Vitro Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 69. Europe Infectious Diseases In Vitro Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 70. Europe Infectious Diseases In Vitro Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 71. Europe Infectious Diseases In Vitro Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 72. Europe Infectious Diseases In Vitro Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 73. Asia-Pacific Infectious Diseases In Vitro Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 74. Asia-Pacific Infectious Diseases In Vitro Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 75. Asia-Pacific Infectious Diseases In Vitro Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 76. Asia-Pacific Infectious Diseases In Vitro Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 77. Asia-Pacific Infectious Diseases In Vitro Diagnostics Revenue by Region (2016-2021) & (USD Million)

Table 78. Asia-Pacific Infectious Diseases In Vitro Diagnostics Revenue by Region (2021-2026) & (USD Million)

Table 79. South America Infectious Diseases In Vitro Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 80. South America Infectious Diseases In Vitro Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 81. South America Infectious Diseases In Vitro Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 82. South America Infectious Diseases In Vitro Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 83. South America Infectious Diseases In Vitro Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 84. South America Infectious Diseases In Vitro Diagnostics Revenue by Country (2021-2026) & (USD Million)

Table 85. Middle East & Africa Infectious Diseases In Vitro Diagnostics Revenue by Type (2016-2021) & (USD Million)

Table 86. Middle East & Africa Infectious Diseases In Vitro Diagnostics Revenue by Type (2021-2026) & (USD Million)

Table 87. Middle East & Africa Infectious Diseases In Vitro Diagnostics Revenue by Application (2016-2021) & (USD Million)

Table 88. Middle East & Africa Infectious Diseases In Vitro Diagnostics Revenue by Application (2021-2026) & (USD Million)

Table 89. Middle East & Africa Infectious Diseases In Vitro Diagnostics Revenue by Country (2016-2021) & (USD Million)

Table 90. Middle East & Africa Infectious Diseases In Vitro Diagnostics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Infectious Diseases In Vitro Diagnostics Picture

Figure 2. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Type in 2020

Figure 3. MRSA

Figure 4. Streptococcus

Figure 5. TB and Drug-resistant TB

Figure 6. Gastro-intestinal Panel Testing

Figure 7. HIV

Figure 8. Hepatitis C

Figure 9. Others

Figure 10. Infectious Diseases In Vitro Diagnostics Revenue Market Share by Application in 2020

Figure 11. Immunochemistry Picture

Figure 12. Molecular Diagnostics Picture

Figure 13. Microbiology Picture

Figure 14. Others Picture

Figure 15. Global Infectious Diseases In Vitro Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 16. Global Infectious Diseases In Vitro Diagnostics Revenue and Forecast (2016-2026) & (USD Million)

Figure 17. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Region (2016-2026)

Figure 18. Global Infectious Diseases In Vitro Diagnostics Revenue Market Share by Region in 2020

Figure 19. North America Infectious Diseases In Vitro Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Europe Infectious Diseases In Vitro Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Asia-Pacific Infectious Diseases In Vitro Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. South America Infectious Diseases In Vitro Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Middle East and Africa Infectious Diseases In Vitro Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 24. Infectious Diseases In Vitro Diagnostics Market Drivers

Figure 25. Infectious Diseases In Vitro Diagnostics Market Restraints

Figure 26. Infectious Diseases In Vitro Diagnostics Market Trends

Figure 27. BD Recent Developments and Future Plans

Figure 28. Abbott Recent Developments and Future Plans

Figure 29. Alere Recent Developments and Future Plans

Figure 30. Quidel Recent Developments and Future Plans

Figure 31. F. Hoffmann-La Roche Recent Developments and Future Plans

Figure 32. Orasure Technologies Recent Developments and Future Plans

Figure 33. Cepheid Recent Developments and Future Plans

Figure 34. Hologic Recent Developments and Future Plans

Figure 35. Qiagen Recent Developments and Future Plans

Figure 36. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 37. Siemens Healthcare Recent Developments and Future Plans

Figure 38. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Players in 2020

Figure 39. Infectious Diseases In Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 40. Global Top 3 Players Infectious Diseases In Vitro Diagnostics Revenue Market Share in 2020

Figure 41. Global Top 10 Players Infectious Diseases In Vitro Diagnostics Revenue Market Share in 2020

Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 43. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Type in 2020

Figure 44. Global Infectious Diseases In Vitro Diagnostics Market Share Forecast by Type (2021-2026)

Figure 45. Global Infectious Diseases In Vitro Diagnostics Revenue Share by Application in 2020

Figure 46. Global Infectious Diseases In Vitro Diagnostics Market Share Forecast by Application (2021-2026)

Figure 47. North America Infectious Diseases In Vitro Diagnostics Sales Market Share by Type (2016-2026)

Figure 48. North America Infectious Diseases In Vitro Diagnostics Sales Market Share by Application (2016-2026)

Figure 49. North America Infectious Diseases In Vitro Diagnostics Revenue Market Share by Country (2016-2026)

Figure 50. United States Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Canada Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Mexico Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Europe Infectious Diseases In Vitro Diagnostics Sales Market Share by Type (2016-2026)

Figure 54. Europe Infectious Diseases In Vitro Diagnostics Sales Market Share by Application (2016-2026)

Figure 55. Europe Infectious Diseases In Vitro Diagnostics Revenue Market Share by Country (2016-2026)

Figure 56. Germany Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. France Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. United Kingdom Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Russia Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Italy Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Asia-Pacific Infectious Diseases In Vitro Diagnostics Sales Market Share by Type (2016-2026)

Figure 62. Asia-Pacific Infectious Diseases In Vitro Diagnostics Sales Market Share by Application (2016-2026)

Figure 63. Asia-Pacific Infectious Diseases In Vitro Diagnostics Revenue Market Share by Region (2016-2026)

Figure 64. China Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Japan Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. South Korea Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. India Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Southeast Asia Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Australia Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. South America Infectious Diseases In Vitro Diagnostics Sales Market Share by Type (2016-2026)

Figure 71. South America Infectious Diseases In Vitro Diagnostics Sales Market Share by Application (2016-2026)

Figure 72. South America Infectious Diseases In Vitro Diagnostics Revenue Market Share by Country (2016-2026)

Figure 73. Brazil Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Argentina Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Middle East and Africa Infectious Diseases In Vitro Diagnostics Sales Market Share by Type (2016-2026)

Figure 76. Middle East and Africa Infectious Diseases In Vitro Diagnostics Sales Market Share by Application (2016-2026)

Figure 77. Middle East and Africa Infectious Diseases In Vitro Diagnostics Revenue Market Share by Country (2016-2026)

Figure 78. Turkey Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Saudi Arabia Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. UAE Infectious Diseases In Vitro Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Methodology

Figure 82. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz